News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
May 7th, 2015
Professors Kit Parker, Marko Loncar, Mikhail Lukin, David Weitz, George Church, and Stuart Schreiber were among the faculty members to be issued U.S. patents this April.
April 1st, 2015
Through academic-industry partnership, a familiar toxin may become a lifesaver for patients with neuromuscular disorders
April 1st, 2015
Paris (France), 1 April 2015 - Ipsen (Euronext: IPN, ADR: IPSEY) announced today that it has signed a multi-year research alliance agreement with Harvard University in Cambridge, Mass.
March 25th, 2015
Professors Eric Mazur, Jene Golovchenko, George Whitesides, and David Weitz are among the faculty members to be issued US patents this March.
March 4th, 2015
NEWTON, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne. The financing follows a worldwide license agreement between Harvard's Office of Technology Development and the company, providing exclusive rights to the technology.